Technische Einblicke

Industrial Synthesis Route For Cholesterol Hydrogen Succinate

  • High-Yield Esterification: Optimized reaction between cholesterol and succinic anhydride ensures consistent throughput.
  • Industrial Purity Standards: Rigorous removal of di-esters and unreacted sterols meets pharmaceutical-grade specifications.
  • Scalable Production: Process designed for bulk procurement with full traceability and Certificate of Analysis (COA) support.

Cholesterol Hydrogen Succinate, frequently identified by its CAS number 1510-21-0, serves as a critical lipid intermediate in the formulation of pH-sensitive liposomes and membrane protein stabilization. As demand increases for advanced drug delivery systems, the need for a robust synthesis route that guarantees industrial purity becomes paramount for process chemists and procurement managers. This article details the manufacturing process, quality control parameters, and commercial scalability of this essential compound.

Chemical Synthesis and Reaction Optimization

The production of Cholesterol Hydrogen Succinate typically involves the esterification of cholesterol with succinic anhydride. This reaction must be carefully controlled to prevent the formation of di-esters or unreacted starting materials, which can compromise the performance of the final lipid assembly. The process generally proceeds under anhydrous conditions using aprotic solvents such as dichloromethane or tetrahydrofuran.

Catalytic agents, often tertiary amines, are employed to facilitate the nucleophilic attack of the cholesterol 3-beta-hydroxyl group on the anhydride. Temperature control is critical; maintaining the reaction between 0°C and 25°C minimizes side reactions. Following the reaction completion, the mixture undergoes acidic workup to isolate the cholesteryl hemisuccinate free acid. This step is crucial for ensuring the correct protonation state required for subsequent salt formation, such as the tris-salt variants used in membrane protein crystallization.

Purification and Quality Control

Achieving industrial purity requires multi-step purification. Recrystallization from solvents like ethyl acetate or ethanol is standard practice to remove residual succinic acid and cholesterol. Advanced manufacturers utilize preparative chromatography to ensure purity levels exceed 98%. Key quality control metrics include:

  • HPLC Analysis: Verification of main peak area and identification of impurities.
  • Residual Solvents: GC analysis to ensure compliance with ICH Q3C guidelines.
  • Water Content: Karl Fischer titration to prevent hydrolysis during storage.

Every batch produced by NINGBO INNO PHARMCHEM CO.,LTD. is accompanied by a comprehensive COA, detailing these specifications to ensure consistency for downstream applications.

Technical Applications in Lipid Formulations

The primary utility of this compound lies in its ability to form stable bilayers that respond to pH changes. In neuroscience research, it is used to enhance the stability of G-protein-coupled receptors (GPCRs) during solubilization and purification. The compound incorporates into detergents, providing a lipid environment that mimics the native cell membrane.

Furthermore, in drug delivery, Cholesterol Hydrogen Succinate is a key component in pH-sensitive liposomes. When mixed with cationic lipids, it creates vesicles that remain stable in plasma but fuse with endosomal membranes upon acidification, facilitating the cytoplasmic delivery of oligonucleotides. Data indicates that liposomes formulated with this intermediate demonstrate high encapsulation efficiency for water-soluble compounds like inulin and chromium, as well as lipid-soluble drugs such as indomethacin.

Encapsulation Efficiency Comparison

The following table summarizes typical encapsulation efficiencies observed in multilamellar vesicles (MLVs) formulated with high-purity cholesterol derivatives compared to standard phospholipids.

Lipid Concentration (mg/ml) Standard Phospholipid Efficiency (%) Cholesterol Hemisuccinate Efficiency (%)
20 2 10
40 4 14
80 5 29
160 8 38
200 11 60

This data underscores the superior capacity of this succinate derivative to sequester aqueous compartments, making it ideal for high-load drug delivery systems.

Commercial Scalability and Procurement

Transitioning from laboratory-scale synthesis to industrial production involves significant engineering challenges. Scaling requires precise control over mixing rates, heat transfer, and filtration processes to maintain batch-to-batch consistency. As a global manufacturer, supply chain reliability is as important as chemical quality. Buyers must consider lead times, packaging integrity, and storage conditions to prevent degradation of the ester linkage.

When sourcing high-purity Cholesteryl Hemisuccinate, buyers should prioritize suppliers who offer transparent documentation regarding the synthesis route and impurity profiles. Bulk price negotiations should account for purity grades, as pharmaceutical-grade material commands a premium over research-grade equivalents due to the stringent testing required.

Storage and Stability

To maintain stability, the material should be stored under inert gas (nitrogen or argon) at temperatures below -20°C. Exposure to moisture or elevated temperatures can lead to hydrolysis, reverting the compound to cholesterol and succinic acid. Proper packaging in amber glass or high-barrier foil bags is essential for long-term storage.

Conclusion

The industrial synthesis of Cholesterol Hydrogen Succinate requires a balance of precise organic chemistry and rigorous quality assurance. From the initial esterification to the final recrystallization, every step impacts the performance of the lipid in critical applications like GPCR stabilization and pH-sensitive drug delivery. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to providing high-quality lipid intermediates that meet the demanding specifications of the pharmaceutical and biotechnology sectors. By adhering to strict manufacturing protocols, we ensure that our clients receive material capable of supporting advanced research and commercial production.